JPWO2021033766A1 - - Google Patents
Info
- Publication number
- JPWO2021033766A1 JPWO2021033766A1 JP2021540988A JP2021540988A JPWO2021033766A1 JP WO2021033766 A1 JPWO2021033766 A1 JP WO2021033766A1 JP 2021540988 A JP2021540988 A JP 2021540988A JP 2021540988 A JP2021540988 A JP 2021540988A JP WO2021033766 A1 JPWO2021033766 A1 JP WO2021033766A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019151943 | 2019-08-22 | ||
PCT/JP2020/031642 WO2021033766A1 (ja) | 2019-08-22 | 2020-08-21 | ビタミンd活性を有するリトコール酸誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2021033766A1 true JPWO2021033766A1 (de) | 2021-02-25 |
Family
ID=74661161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021540988A Pending JPWO2021033766A1 (de) | 2019-08-22 | 2020-08-21 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2021033766A1 (de) |
WO (1) | WO2021033766A1 (de) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7012069B2 (en) * | 2001-05-03 | 2006-03-14 | Arch Development Corporation | Liver X receptor agonists |
JP2019055913A (ja) * | 2016-01-28 | 2019-04-11 | 国立大学法人お茶の水女子大学 | ビタミンd活性を有するリトコール酸誘導体 |
CN109364084A (zh) * | 2018-11-27 | 2019-02-22 | 深圳市绘云生物科技有限公司 | 一种治疗血糖、血脂异常及神经退行性疾病的药物及其制剂 |
-
2020
- 2020-08-21 WO PCT/JP2020/031642 patent/WO2021033766A1/ja active Application Filing
- 2020-08-21 JP JP2021540988A patent/JPWO2021033766A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021033766A1 (ja) | 2021-02-25 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20220216 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220218 |
|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20220317 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230731 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240521 |